Clinical impact of differential risk stratification by breast cancer index (BCI) versus recurrence score (RS) in HR+ early-stage breast cancer: A TransATAC study

Authors :: Mark G. Erlander
Mitchell Dowsett
Ivana Sestak
Brock Schroeder
Catherine A. Schnabel
Jack Cuzick
Paul E. Goss
Dennis C. Sgroi
Yi Zhang
Source :: Journal of Clinical Oncology. 32:532-532
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: 532 Background: BCI is a genomic signature that significantly predicts risk of both early (0-5y) and late (5-10y) distant recurrence (DR) in HR+, LN- breast cancer. Previous results from the TransA...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Distant recurrence
Recurrence score
Genomic signature
Bioinformatics
medicine.disease
Breast cancer
Internal medicine
Risk stratification
Medicine
Stage (cooking)
business

Full Text Access

Tools